The American Gastroenterological Association has updated guidance for the treatment of ulcerative colitis to recommend using higher efficacy drugs in earlier stages of treatment, Medscape Medical News ...
Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by recurrent intestinal inflammation, abdominal ...
Everyday Health on MSN
Why histological healing is the new benchmark for your ulcerative colitis
For people with UC, ‘feeling better’ is just the start. Learn why tissue-level (histological) healing is becoming the new ...
Everyday Health on MSN
How to manage a career and family during an ulcerative colitis treatment switch
Switching UC treatments while managing a career and home life can be a major challenge. Here’s how to navigate work logistics, family communication, and side effects.
Explore the latest advancements in treating ulcerative colitis using machine learning to discover new antimicrobial peptides.
Please provide your email address to receive an email when new articles are posted on . A greater proportion of patients in the PRA023 group achieved clinical remission at 12 weeks vs. placebo (26.5% ...
A machine learning-based computational approach to accelerate therapeutic discoveryUlcerative colitis (UC) is a chronic inflammatory bowel disease ...
How Does Tremfya Work for Ulcerative Colitis? Tremfya is a monoclonal antibody that reduces inflammation. The main ingredient in Tremfya is a medicine called guselkumab. This medicine blocks a ...
(MENAFN- EIN Presswire) EINPresswire/ -- Ulcerative Colitis Market to Surpass $26 billion in 2030. Within the broader Healthcare Services industry, which is expected to be $10,759 billion by 2030, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results